Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics
The Broad Institute’s Cancer Dependency Map Consortium (DMC) is an academic-industry collaboration that has transformed the study of cancer by developing one of the most comprehensive inventories of tumor vulnerabilities. Launched in late 2018, the DMC is …